However, the inhibition of LC3B induced by UBA5 could be reversed by usenamine A. Thus, usenamine A is a promising therapeutic agent for breast cancer, and further research efforts should focus on elucidating the mechanisms in detail. The gene discussed is MAP1LC3B; the disease is breast carcinoma.